Probiotic-based Antiviral Solutions for Specialized Environments
Legal Citation
Summary of the Inventive Concept
This inventive concept adapts antiviral methods and compositions comprising probiotic bacterial molecules for specific, high-need markets, including high-security facilities, disaster relief zones, extreme weather environments, high-density confined spaces, and immune-compromised individuals.
Background and Problem Solved
The original patent disclosed antiviral methods and compositions using probiotic bacterial molecules. However, these solutions were not tailored to address the unique challenges of specialized environments, where the risk of viral infections is heightened. This inventive concept addresses these limitations by providing targeted solutions for these specific markets.
Detailed Description of the Inventive Concept
The inventive concept comprises four key variations: (1) a secure, tamper-evident delivery system for high-security facilities, (2) a composition adapted for extreme weather conditions in disaster relief zones, (3) a portable, ruggedized delivery device for remote, extreme weather environments, and (4) a ventilation system adapted to distribute the composition throughout high-density, confined spaces. These variations leverage the antiviral properties of probiotic bacterial molecules to provide effective solutions for these niche markets.
Novelty and Inventive Step
The new claims introduce novel elements, such as secure delivery systems, weather-resistant compositions, and specialized ventilation systems, which are not present in the original patent. These elements, combined with the probiotic bacterial molecules, provide a non-obvious solution for the specific challenges of these specialized environments.
Alternative Embodiments and Variations
Alternative embodiments could include customized packaging for specific environments, integration with existing infrastructure in high-density spaces, or adaptation of the composition for specific viral strains. These variations would ensure broad conceptual coverage and potential applications in various industries.
Potential Commercial Applications and Market
The inventive concept has significant commercial potential in industries such as biotechnology, healthcare, and disaster relief. The targeted solutions for high-security facilities, disaster relief zones, and extreme weather environments could generate significant revenue streams. Additionally, the potential for licensing and partnerships with government agencies, NGOs, and private companies could further expand the market reach.
Section 103 Obviousness Analysis (PHOSITA)
Field of Art
Microbiology, virology, and probiotic therapeutic interventions, with expertise in bacterial molecular compositions and antiviral treatments
Person of Ordinary Skill (PHOSITA) Profile
A microbiologist or biotechnology researcher with advanced degree, familiar with probiotic bacterial strains, viral infection mechanisms, and therapeutic delivery systems
Obviousness Rationale
A person skilled in the art would recognize that the source patent's fundamental approach of using probiotic bacterial molecules for viral treatment provides a clear technical foundation for adapting the technology to specialized environments. The PTD's variations represent predictable extensions of the original antiviral method, applying known probiotic principles to specific use cases with standard engineering modifications. The core scientific mechanism remains consistent across the proposed variations, with only contextual adaptations to delivery and environmental constraints.
Obvious Combinations & Variations
Original Patent Information
| Patent Number | US 11,857,581 |
|---|---|
| Title | Antiviral methods and compositions comprising probiotic bacterial molecules |
| Assignee(s) | MICROSINTESIS INC. |